A clinico-genetic study of antiplatelet response in clopidogrel treated patients undergoing percutaneous coronary intervention – CYP2C19 polymorphism pattern analysis

Genetic Study ◽

Pattern Analysis ◽

Coronary Intervention ◽

Cyp2c19 Polymorphism ◽

Percutaneous Coronary ◽

Polymorphism Pattern

Impact of CYP2C19 Polymorphism on Platelet Function Tests and Coagulation and Inflammatory Biomarkers in Patients Undergoing Percutaneous Coronary Intervention

Journal of Atherosclerosis and Thrombosis ◽

10.5551/jat.18952 ◽

2014 ◽

pp. 64-76 ◽

Cited By ~ 11

Author(s):

Koichi Kaikita ◽

Takamichi Ono ◽

Satomi Iwashita ◽

Naoki Nakayama ◽

Koji Sato ◽

...

Keyword(s):

Platelet Function ◽

Coronary Intervention ◽

Inflammatory Biomarkers ◽

Platelet Function Tests ◽

Function Tests ◽

Cyp2c19 Polymorphism ◽

RELEVANCE OF THE CYP2C19 POLYMORPHISM FOR LOADING AND MAINTENANCE DOSE OF PRASUGREL AND CLOPIDOGREL TREATMENT EFFECT IN CORONARY ARTERY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION PCI : THE PRAISE-GENE STUDY

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(16)30209-1 ◽

2016 ◽

Vol 67 (13) ◽

pp. 208 ◽

Cited By ~ 1

Author(s):

Moo Hyun Kim ◽

Long Zhe Guo ◽

Eun-Seok Shin ◽

Soe Hee Ann ◽

Sun Young Choi ◽

...

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Treatment Effect ◽

Maintenance Dose ◽

Coronary Intervention ◽

Cyp2c19 Polymorphism ◽

Percutaneous Coronary ◽

Artery Disease ◽

Gene Study

Diabetes and CYP2C19 Polymorphism Synergistically Impair the Antiplatelet Activity of Clopidogrel Compared With Ticagrelor in Percutaneous Coronary Intervention–treated Acute Coronary Syndrome Patients

Journal of Cardiovascular Pharmacology ◽

10.1097/fjc.0000000000000881 ◽

2020 ◽

Vol 76 (4) ◽

pp. 478-488

Author(s):

Mina W. Mohareb ◽

Mohamed AbdElghany ◽

Hala F. Zaki ◽

Hanan S. El-Abhar

Keyword(s):

Acute Coronary Syndrome ◽

Coronary Intervention ◽

Antiplatelet Activity ◽

Coronary Syndrome ◽

Cyp2c19 Polymorphism ◽

GW27-e0576 Relevance of the CYP2C19 Polymorphism for Loading and Maintenance dose of Prasugrel and Clopidogrel Treatment Effect in Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: The PRAISE-GENE Study

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2016.07.355 ◽

2016 ◽

Vol 68 (16) ◽

pp. C95

Author(s):

Moo Hyun Kim ◽

Long Zhe Guo ◽

Eun-Seok Shin ◽

Soe Hee Ann ◽

Young-Rak Cho ◽

...

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Treatment Effect ◽

Maintenance Dose ◽

Coronary Intervention ◽

Cyp2c19 Polymorphism ◽

Percutaneous Coronary ◽

Artery Disease ◽

Gene Study

Risk of Restenosis and Health Status Outcomes for Patients Undergoing Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery

Yearbook of Anesthesiology and Pain Management ◽

10.1016/s1073-5437(08)70317-6 ◽

2006 ◽

Vol 2006 ◽

pp. 49-50

Author(s):

M.F. Roizen

Keyword(s):

Health Status ◽

Coronary Artery ◽

Coronary Artery Bypass Graft ◽

Coronary Artery Bypass ◽

Artery Bypass ◽

Bypass Graft ◽

Coronary Intervention ◽

Artery Bypass Graft ◽

409 Haemodynamic parameters in cardiogenic shock due to myocardial infarction: effects of levosimendan compared with dobutamine after primary percutaneous coronary intervention

European Journal of Heart Failure Supplements ◽

10.1016/s1567-4215(05)80252-8 ◽

2005 ◽

Vol 4 (1) ◽

pp. 92-93

Keyword(s):

Myocardial Infarction ◽

Cardiogenic Shock ◽

Primary Percutaneous Coronary Intervention ◽

Coronary Intervention ◽

Haemodynamic Parameters ◽

P2870 Elective percutaneous coronary intervention using anti-platelet therapy alone, without unfractionated heparin or other anti-thrombin therapy

10.1016/s0195-668x(03)95648-x ◽

2003 ◽

Vol 24 (5) ◽

pp. 548

Author(s):

S DENARDO

Keyword(s):

Unfractionated Heparin ◽

Coronary Intervention ◽

Elective Percutaneous Coronary Intervention ◽

Anti Platelet Therapy ◽

P2846 Adverse outcomes in patients experiencing thrombocytopenia following percutaneous coronary intervention: a pooled analysis of abciximab studies

10.1016/s0195-668x(03)95624-7 ◽

2003 ◽

Vol 24 (5) ◽

pp. 541

Author(s):

H JAMAL

Keyword(s):

Coronary Intervention ◽

Pooled Analysis ◽

Adverse Outcomes ◽

P1627 Does infarct size measured by creatine kinase-MB predict clinical outcomes after fibrinolysis and primary percutaneous coronary intervention?

10.1016/s0195-668x(03)94765-8 ◽

2003 ◽

Vol 24 (5) ◽

pp. 301

Author(s):

K MAHAFFEY

Keyword(s):

Creatine Kinase ◽

Infarct Size ◽

Clinical Outcomes ◽

Primary Percutaneous Coronary Intervention ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Creatine Kinase Mb

P1095 Antecedent thrombolytic therapy followed by planned rescue percutaneous coronary intervention for acute myocardial infarction, compared with primary percutaneous coronary intervention

10.1016/s0195-668x(03)94387-9 ◽

2003 ◽

Vol 24 (5) ◽

pp. 197

Author(s):

T HASUDA

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Thrombolytic Therapy ◽

Primary Percutaneous Coronary Intervention ◽

Coronary Intervention ◽